2-Propyl-2-pentenoic acid

Chemodex
Product Code: CDX-P0155
Product Group: Other Biochemicals
Supplier: Chemodex
CodeSizePrice
CDX-P0155-M02525 mg£261.00
Quantity:
CDX-P0155-M05050 mg£431.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
Ambient
Storage:
+4°C

Images

1 / 1
Chemical Structure

Chemical Structure

Further Information

Alternate Names/Synonyms:
2-en-VPA; Delta2-Valproic acid; 2-Propyl-2-pentenoate; 2-Propylpenten-2-oic acid
Appearance:
White crystalline powder.
CAS:
60218-41-9
Class:
6.1
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS06
Handling Advice:
Keep cool and dry.Protect from light and moisture.
Hazards:
H301
InChi:
InChI=1S/C8H14O2/c1-3-5-7(6-4-2)8(9)10/h5H,3-4,6H2,1-2H3,(H,9,10)/b7-5+
InChiKey:
ZKNJEOBYOLUGKJ-FNORWQNLSA-N
Long Description:
Chemical. CAS: 60218-41-9. Formula: C8H14O2. MW: 142.2. Synthetic A major beta-oxidation metabolite of valproic acid (VPA). Exhibits anticonvulsive potency similar to VPA and may be at least partially responsible for its neurological activity. Compound can be used as analytical reference material.
MDL:
MFCD00801107
Molecular Formula:
C8H14O2
Molecular Weight:
142.2
Package Type:
Vial
PG:
III
Precautions:
P301, P310
Product Description:
A major beta-oxidation metabolite of valproic acid (VPA). Exhibits anticonvulsive potency similar to VPA and may be at least partially responsible for its neurological activity. Compound can be used as analytical reference material.
Purity:
>98% (GC)
Signal word:
Danger
SMILES:
CCCC(=CCC)C(O)=O
Solubility Chemicals:
Soluble in chloroform, ether or methanol.
Source / Host:
Synthetic
Transportation:
Excepted Quantity
UN Nummer:
UN 2811
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

(1) R. Misslin, et al.; Psychopharmacol. 50, 53 (1976) | (2) W. L?scher & H. Nau; J. Pharmacol. Exp. Ther. 226, 845 (1983) | (3) M.J. McLean, et al.; J. Pharmacol. Exp. Ther. 237, 1001 (1986) | (4) R.D. Lee, et al.; J. Pharm. Sci. 78, 667 (1989) | (5) D. H?nack, et al.; Naunyn Schmiedebergs Arch. Pharmacol. 345, 187 (1992)